Multidrug-resistant Gram-negative bacteria: how to treat and for how long

This publication has 44 references indexed in Scilit:

• An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
  Clinical Infectious Diseases, 2010
• Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
  The Lancet, 2010
• Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
  International Journal of Antimicrobial Agents, 2010
• ACHN-490, a Neoglycoside with Potent In Vitro Activity against Multidrug-Resistant Klebsiella pneumoniae Isolates
  Antimicrobial Agents and Chemotherapy, 2009
• In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
  Journal of Antimicrobial Chemotherapy, 2009
• Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolates?
  Antimicrobial Agents and Chemotherapy, 2009
• Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
  Antimicrobial Agents and Chemotherapy, 2009
• Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
  Antimicrobial Agents and Chemotherapy, 2009
• Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
  Clinical Infectious Diseases, 2009
• In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals
  Antimicrobial Agents and Chemotherapy, 2006